Pearl joined Bayer UK in 1993 as a Clinical Research Scientist, and over the years has held positions within Monitoring, Study Management, Line Management, Outsourcing and Operational Support across a variety of therapeutic areas. She spent a year working in Bayer’s New Jersey office.

In April 2011, she was appointed Head, CAPA Management within the Business Excellence Function of Bayer’s Global Development Quality Department, and was responsible for directing the CAPA strategy for Global Development. This included standard setting and the development of a harmonized CAPA process and CAPA Tool. Pearl established and leads a cross-functional CAPA Council that oversees the tracking, collation, analysis and reporting of CAPAs for Pharma R&D (Bayer).

In 2013, Pearl was appointed Head of Compliance Management within Bayer’s Global R&D Quality Department, leading a small team with responsibility for supporting CAPA, Risk Management and Quality Governance for Pharma R&D (Bayer).